Antiphospholipid Syndrome Challenges in the Laboratory Diagnosis and Treatment A/Prof P Kuperan FRCP, FRCPA, FRCPath Head & Senior Consultant Department of Haematology…

1. ATRIAL FIBRILLATIONDr SYED RAZA MD,MRCP(UK),CCT(UK),MESC,Dip.Card(UK),FCCPConsultant Cardiologist 2. OBJECTIVES• Introduction• Classification• Burden of the problem•…

Slide 1Raju Kucherlapati, Ph.D. Harvard Medical School Partners Healthcare Genetics and Genomics in Clinical Medicine Slide 2 Healthcare Issues Healthcare costs are rising…

Slide 1Whats new in EP? Say no to drugs? Lionel Faitelson MD FACC FHRS Tucson Heart Group TMC Cardiovascular Symposium 2012 Slide 2 New devices for arrhythmias? Anti-arrhythmic…

Slide 1Evidence-Based Management of Anticoagulant Therapy ----- Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-…

1. Case presentation Kamal Osman Mirghani,MD,FSCCM Internal Medicine & Critical Care Consultant Clinical Director of ICU department Omdurman military Hospital [email protected]…

1. Progress in Lupus Trial Design Contact: [email protected] 2. Patients Trial design Interventions Endpoints ⏏ ⏏ 3 key design factors determine the fate of clinical…

1. By Salman Ahmed 2. Introduction  Observational studies have identified two genes, CYP2C9 and VKORC1, that are associated with variation in warfarin maintenance doses…

Antithrombotic Therapy for Venous Thromboembolic Disease * : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Clive Kearon,…

1. • I Международный Форум…